Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
2.550
+0.080 (3.23%)
Nov 21, 2024, 2:37 PM EST - Market open
Purple Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
5.08M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sunshine Biopharma | 32.96M |
Applied DNA Sciences | 3.40M |
Kindly MD | 2.88M |
Predictive Oncology | 1.48M |
Cyclerion Therapeutics | 194.00K |
Silo Pharma | 72.10K |
PPBT News
- 6 days ago - Purple Biotech Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 17 days ago - Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death - GlobeNewsWire
- 27 days ago - Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 6 weeks ago - Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 2 months ago - Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24 - GlobeNewsWire
- 2 months ago - Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Purple Biotech Reports Second Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 4 months ago - Purple Biotech Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price Rule - GlobeNewsWire